Advertisement
UK markets open in 2 hours 6 minutes

  • NIKKEI 225

    38,018.18
    +389.70 (+1.04%)
     

  • HANG SENG

    17,626.75
    +342.21 (+1.98%)
     

  • CRUDE OIL

    83.86
    +0.29 (+0.35%)
     

  • GOLD FUTURES

    2,347.20
    +4.70 (+0.20%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • Bitcoin GBP

    51,435.52
    -18.30 (-0.04%)
     

  • CMC Crypto 200

    1,387.31
    +4.73 (+0.34%)
     

  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     

  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Company News For Jan 2, 2020

Zacks Equity Research

  • Shares of Neovasc Inc. NVCN soared nearly 37% after the company announced that it had submitted a premarket approval application to the U.S. Food and Drug Administration for Neovasc Reducer, used in treatment of refractory angina

  • Shares of Viveve Medical, Inc. VIVE jumped 46.5% after the company announced that it has regained compliance with Nasdaq listing rules

  • Shares of Seadrill Limited SDRL rose 7.2% after the company reported that it has received a 3-year contract for AOD II and AOD III, which is expected to be $98 million and $101 million in value

  • Shares of Urovant Sciences Ltd. UROV rose 18.4% after the company reported submission of New Drug Application for Vibegron, used for the treatment of overactive bladder


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Neovasc Inc. (NVCN) : Free Stock Analysis Report
 
Viveve Medical, Inc. (VIVE) : Free Stock Analysis Report
 
Urovant Sciences Ltd. (UROV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research